Ireland Natalizumab (TYSABRI) Observational Program

Clinical trial NCT01943526 · COMPLETED

Trial details

NCT number: NCT01943526
Sponsor: Biogen
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2011-11-30
Primary completion: 2017-12-31
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.